Trials / Completed
CompletedNCT00790660
A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.
A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Multiple Dose Study to Assess the Safety and Tolerability of ASP1941 in Adult Subjects With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to assess safety and tolerability of ASP1941 compared to placebo in adult subjects with type 2 diabetes mellitus
Detailed description
Trial includes a two week washout period before entering the treatment period for subjects on oral anti-diabetic medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP1941 | Oral |
| DRUG | Placebo | Oral |
Timeline
- Start date
- 2008-10-23
- Primary completion
- 2009-03-06
- Completion
- 2009-03-06
- First posted
- 2008-11-13
- Last updated
- 2024-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00790660. Inclusion in this directory is not an endorsement.